IP Library Granted Patent US 8,105,491
Granted Patent B2
US 8,105,491 · App. 11/064,566 · Granted Jan 31, 2012

Metabolic detoxification and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,105,491
App. No.
11/064,566
Granted
Jan 31, 2012
Kind
B2
Abstract

An extracorporeal filtration and detoxification system and method generally comprise separating ultrafiltrate from cellular components of blood, treating the ultrafiltrate independently of the cellular components in a recirculation circuit, recombining treated ultrafiltrate and the cellular components, and returning whole blood to the patient. A recirculation circuit generally comprises an active cartridge including active cells operative to effectuate a selected treatment; in some embodiments, the active cells are the C3A cell line.

Claims (25)

1. An extracorporeal filtration method, the method comprising the steps of:

(a) drawing blood from a patient;

(b) separating ultrafiltrate fluid from cellular components of said blood;

(c) optionally, infusing said separated ultrafiltrate fluid with glucose;

(d) infusing oxygen into the separated ultrafiltrate fluid;

(e) treating said separated ultrafiltrate fluid independently of said cellular components in a recirculation circuit, wherein said treating comprises circulating said separated ultrafiltrate fluid through an active cartridge comprising active cells operative to effectuate a selected treatment of said separated ultrafiltrate fluid, wherein said active cells are the C3A cell line;

(f) recombining said treated ultrafiltrate fluid and said cellular components; and

(g) returning whole blood comprising said recombined, treated ultrafiltrate fluid and said cellular components to the patient,

with the proviso that said separated ultrafiltrate fluid is analyzed either prior or subsequent to said treating step (e) but before said recombining step (f), wherein the analysis comprises monitoring of oxygen and pH differentials across the active cartridge.

2. The method of claim 1 , wherein said drawing comprises utilizing a first lumen of a double lumen catheter and wherein said returning comprises utilizing a second lumen of said double lumen catheter.

3. The method of claim 1 , wherein said drawing comprises utilizing a blood pump operative to circulate said blood from the patient, through an ultrafiltrate generator, and back to the patient at a selected flow rate.

4. The method of claim 1 , wherein said separating comprises utilizing an ultrafiltrate generator comprising a hollow fiber filter cartridge.

5. The method of claim 4 , wherein said utilizing comprises drawing said ultrafiltrate through a semi-permeable membrane of said hollow fiber filter cartridge.

6. The method of claim 5 , wherein said semi-permeable membrane has a pore size of approximately 0.2μm.

7. The method of claim 5 , wherein said semi-permeable membrane has a pore size of approximately 0.1μm.

8. The method of claim 5 , wherein said semi-permeable membrane has a nominal molecular weight cut-off of about 100,000 Daltons.

9. The method of claim 5 , wherein said drawing comprises implementing a ultrafiltrate pump.

10. The method of claim 1 , further comprising the step of infusing said drawn blood of step (a) with an anticoagulation agent.

11. The method of claim 1 , wherein said treating further comprises maintaining said ultrafiltrate at a predetermined temperature.

12. The method of claim 11 , wherein said treating further comprises maintaining said ultrafiltrate at approximately 37° C.

13. The method of claim 1 , further comprising filtering said ultrafiltrate prior to said recombining.

14. The method of claim 13 , wherein said filtering comprises utilizing a hollow fiber filter.

15. The method of claim 13 , wherein said filtering comprises utilizing one or more of a detoxification device, an ammonia trap, and a mechanical filter.

16. The method of claim 1 , wherein said returning comprises detecting and removing gaseous contaminants in said whole blood.

17. The method of claim 1 , wherein said returning comprises regulating a flow rate of said whole blood to the patient.

Assignments (13)
CHANGE OF NAME Recorded Aug 15, 2023
From: VITAL THERAPIES, INC.
To: IMMUNIC, INC.
Reel/Frame 064591/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2023
From: IMMUNIC, INC.
To: RH CELL THERAPEUTICS CORP.
Reel/Frame 064591/0754 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2013
From: BROTHERTON, JOHN D; HE, DAR
To: VITAL THERAPIES, INC.
Reel/Frame 031385/0640 →
RELEASE AND TERMINATION OF SECURITY INTEREST Recorded Sep 21, 2012
From: JAFFE, ROSS, MD; CAPITAL VENTURES INTERNATIONAL BY HEIGHTS CAPITAL MANAGEMENT, INC.; WINTERS, TERENCE E., MR.; VERSANT VENTURE CAPITAL III, L.P.; VERSANT SIDE FUND III, L.P.; MEDVENTURE ASSOCIATES V, L.P.; MEDVEN AFFILIATES V, L.P.; VALLEY VENTURES III, L.P.; VALLEY VENTURES III ANNEX, L.P.; LANDMARK EQUITY PARTNERS XIII, L.P.; COTTON FAMILY LIMITED PARTNERSHIP, LLP; WEDBUSH MORGAN SEC. CTDN IRA FOR JOHN C. COTTON A/C 2750-0064; COTTON, JOHN C., MR.; COTTON, JANET H., MS.; RENZE, PAUL J., MR.; CRAMER TAOS PARTNERS C/O GOM CAPITAL; JOURNEYS END PARTNERS C/O GOM CAPITAL; GREENWOOD GULCH VENTURES, LLC; ROBERT F. KIBBLE LIVING TRUST DATED 12/28/1990; VANESSA KIBBLE 2004 HOLDING TRUST; ROBERT F.J. KIBBLE 2003 HOLDING TRUST; SHABAR COBB 2004 HOLDING TRUST; STEVEN J. PFRENZINGER AND MARGARET A. PFRENZINGER FAMILY TRUST DATED 03/25/83; KUNG FAMILY TRUST DATED 2/8/2002; BAUM, KEITH W., MR.; STEER, RANDY C., MR.; JOANN M. OROVITZ TRUST DATED 9/7/1995; MARCUS, RAULEE; WEISS, JOSEPH B., MR.; STERN, ARON, MR.; ENGLEMAN FAMILY TRUST; FLORIO, JACK, MR.; ZANDER, TROY, MR.; CAPITAL VENTURE INTERNATIONAL HEIGHTS CAPITAL MANAGEMENT, INC.; WINTERS, TERENCE E, MR.; EQUITY TRUST COMPANY D/B/A STERLING TRUST CUSTODIAN F/B/O JOHN LEWIS; DFJ DRAGONFUND CHINA, L.P.; DFJ DRAGONFUND PARTNERS, LLC; DRAPER FISHER JURVETSON FUND VIII, L.P.; DRAPER FISHER JURVETSON PARTNERS VIII, LLC; JABE, LLC; TOUCAN CAPITAL FUND II, L.P.; PFRENZINGER, STEVEN J., MR.; PFRENZINGER-JULIANEL, CHRISTINE, MS.; KUNG, FRANK, MR.; JOHN S. AND ELIZABETH H. LEWIS FAMILY PARTNERSHIP LP; RAULEE MARCUS LIVING TRUST DATED 4/9/10; BEIJING RENKAI INVESTMENT CO., LTD.; ZHANG, ZHENAN
To: VITAL THERAPIES, INC.
Reel/Frame 029026/0709 →
RELEASE AND TERMINATION OF SECURITY INTEREST Recorded Apr 25, 2012
From: CAPITAL VENTURES INTERNATIONAL BY HEIGHTS CAPITAL MANAGEMENT, INC.; WINTERS, TERENCE E, MR.; VERSANT VENTURE CAPITAL III, L.P.; VERSANT SIDE FUND III, L.P.; MEDVENTURE ASSOCIATES V, L.P.; MEDVEN AFFILIATES V, L.P.; VALLEY VENTURES III, L.P.; VALLEY VENTURES III ANNEX, L.P.; LANDMARK EQUITY PARTNERS XIII, L.P.; COTTON FAMILY LIMITED PARTNERSHIP, LLP; WEDBUSH MORGAN SEC. CTDN IRA FOR JOHN C. COTTON A/C 2750-0064; COTTON, JOHN C., MR.; COTTON, JANET H., MS.; RENZE, PAUL J., MR.; CRAMER TAOS PARTNERS C/O GOM CAPITAL; JOURNEYS END PARTNERS C/O GOM CAPITAL; GREENWOOD GULCH VENTURES, LLC; ROBERT F. KIBBLE LIVING TRUST DATED 12/28/1990; VANESSA KIBBLE 2004 HOLDING TRUST; ROBERT F.J. KIBBLE 2003 HOLDING TRUST; SHABAR COBB 2004 HOLDING TRUST; STEVEN J. PFRENZINGER AND MARGARET A. PFRENZINGER FAMILY TRUST DATED 03/25/1983; KUNG FAMILY TRUST DATED 02/08/2002; BAUM, KEITH W., MR.; STEER, RANDY C., MR.; JOANN M. OROVITZ TRUST DATED 09/07/1995; MARCUS, RAULEE; WEISS, JOSEPH B., MR.; STERN, ARON; ENGLEMAN FAMILY TRUST; FLORIO, JACK, MR.; ZANDER, TROY, MR.; CAPITAL VENTURE INTERNATIONAL HEIGHTS CAPITAL MANAGEMENT, INC.; WINTERS, TERENCE E., MR.; EQUITY TRUST COMPANY D/B/A STERLING TRUST CUSTODIAN F/B/O JOHN LEWIS; DFJ DRAGONFUND CHINA, L.P.; DFJ DRAGONFUND PARTNERS, LLC; DRAPER FISHER JURVETSON FUND VIII, L.P.; DRAPER FISHER JURVETSON PARTNERS VIII, LLC; JABE, LLC; TOUCAN CAPITAL FUND II, L.P.; PFRENZINGER, STEVEN J., MR.; PFRENZINGER-JULIANEL, CHRISTINE, MS.; KUNG, FRANK, MR.; JOHN S. AND ELIZABETH H. LEWIS FAMILY PARTNERSHIP LP; RAULEE MARCUS LIVING TRUST DATED 04/09/2010; BEIJING RENKAI INVESTMENT CO., LTD.; ZHANG, ZHENAN
To: VITAL THERAPIES, INC.
Reel/Frame 028108/0647 →
SECURITY AGREEMENT Recorded Nov 5, 2010
From: VITAL THERAPIES, INC., A DELAWARE CORPORATION
To: ZHANG, ZHENAN
Reel/Frame 025319/0217 →
SECURITY AGREEMENT Recorded Aug 13, 2010
From: VITAL THERAPIES, INC.
To: RAULEE MARCUS LIVING TRUST DATED 4/9/10; BEIJING RENKAI INVESTMENT CO., LTD.
Reel/Frame 024823/0898 →
SECURITY AGREEMENT Recorded May 5, 2010
From: VITAL THERAPIES, INC.
To: PFRENZINGER, STEVEN J.; PFRENZINGER-JULIANEL, CHRISTINE; KUNG, FRANK; JOHN S. AND ELIZABETH H. LEWIS FAMILY PARTNERSHIP LP
Reel/Frame 024337/0972 →
SECURITY AGREEMENT Recorded Dec 24, 2009
From: VITAL THERAPIES, INC.
To: EQUITY TRUST COMPANY DBA STERLING TRUST CUSTODIAN FBO JOHN LEWIS; DFJ DRAGONFUND CHINA, L.P.; DFJ DRAGONFUND PARTNERS, LLC; DRAPER FISHER JURVETSON FUND VIII, L.P.; DRAPER FISHER JURVETSON PARTNERS VIII, LLC; JABE, LLC; TOUCAN CAPITAL FUND II, L.P.
Reel/Frame 023699/0704 →
SECURITY AGREEMENT Recorded Nov 25, 2009
From: VITAL THERAPIES, INC.
To: CAPITAL VENTURES INTERNATIONAL, HEIGHTS CAPITAL MANAGEMENT, INC.; WINTERS, TERENCE E.
Reel/Frame 023565/0911 →
SECURITY AGREEMENT Recorded Oct 28, 2009
From: VITAL THERAPIES, INC.
To: CAPITAL VENTURES INTERNATIONAL BY HEIGHTS CAPITAL MANAGEMENT, INC.; WINTERS, TERENCE E.
Reel/Frame 023438/0044 →
SECURITY AGREEMENT Recorded Sep 29, 2009
From: VITAL THERAPIES, INC.
To: VERSANT VENTURE CAPITAL III, L.P.; VERSANT SIDE FUND III, L.P.; MEDVENTURE ASSOCIATES V, L.P.; MEDVEN AFFILIATES V, L.P.; VALLEY VENTURES III, L.P.; VALLEY VENTURES III ANNEX, L.P.; LANDMARK EQUITY PARTNERS XIII, L.P.; COTTON FAMILY LIMITED PARTNERSHIP, LLP, C/O THE MARICOPA PARTNERSHIPS, LLC; WEDBUSH MORGAN SEC CTDN IRA FOR JOHN C. COTTON A/C 2750-0064 C/O WEDBUSH MORGAN SECURITIES, INC.; COTTON, JOHN C; COTTON, JANNET H; RENZE, PAUL J; CRAMER TAOS PARTNERS C/O GOM CAPITAL; JOURNEYS END PARTNERS C/O GOM CAPITAL; GREENWOOD GULCH VENTURES, LLC; ROBERT F. KIBBLE LIVING TRUST DATED 12/28/1990; VANESSA KIBBLE 2004 HOLDING TRUST; ROBERT F.J. KIBBLE 2003 HOLDING TRUST; SHABAR COBB 2004 HOLDING TRUST; STEVEN J. PFRENZINGER AND MARGARET A. PFRENZINGER FAMILY TRUST DATED 03/25/83; KUNG FAMILY TRUST DATED 2/8/2002; KEITH W. BAUM; RANDY C. STEER; JOANN M. OROVITZ TRUST DATED 9/7/1995; RAULEE MARCUS; JOSEPH B. WEISS; ARON STERN; ENGLEMAN FAMILY TRUST; JACK FLORIO; TROY ZANDER
Reel/Frame 023292/0611 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2005
From: BROTHERTON, JOHN D.; HE, DAR
To: VITAL THERAPIES, INC.
Reel/Frame 016553/0422 →